Research

Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment
2024 Spoke 6 Oncology and innovative therapies

Guido Giordano, Michele Milella, Matteo Landriscina, Francesca Bergamo, Giuseppe Tirino, Antonio Santaniello, Alberto Zaniboni, Enrico Vasile, Ferdinando De Vita, Giovanni Lo Re, Vanja Vaccaro, Elisa Giommoni, Donato Natale, Raffaele Conca, Daniele Santini, Luigi Maiorino, Gianni Sanna, Vincenzo Ricci, Aldo Iop, Vincenzo Montesarchio, Letizia Procaccio, Silvia Noventa, Roberto Bianco, Antonio Febbraro, Sara Lonardi, Giampaolo Tortora, Isabella Sperduti, Davide Melisi

Lung function trajectories in common variable immunodeficiencies: An observational retrospective multicenter study
2025 Spoke 5 Respiratory system and related systemic diseases

Helena Buso, Davide Firinu, Renato Finco Gambier, Riccardo Scarpa, Giulia Garzi, Valentina Soccodato, Giulia Costanzo, Andrea G. Ledda, Nicolò Rashidy, Ilaria Bertozzi, Stefania Nicola, Giulio Tessarin, Mauro Ramigni, Cinzia Piovesan, Fabrizio Vianello, Andrea Vianello, Stefano Del Giacco, Vassilios Lougaris, Luisa Brussino, Mark G. Jones, Isabella Quinti, Carlo Agostini, Marcello Rattazzi, Cinzia Milito, Francesco Cinetto

Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model
2024 Spoke 4 Advanced diagnostics

Giorgio Cazzaniga, Vincenzo L’Imperio, Emanuela Bonoldi, María-Carlota Londoño, João Madaleno, Augusta Cipriano, Tom J G Gevers, Iryna V Samarska, Özgür M Koc, Alejandra Villamil, Maria Florencia Sanchez, Vincenza Calvaruso, Alberto Quattrocchi, Daniela Cabibi, Bastian Engel, Federica Malinverno, Elisa Merelli, Laura Cristoferi, Marco Carbone, Fabio Pagni, Pietro Invernizzi, Alessio Gerussi

Structure-based mechanism of riboregulation of the metabolic enzyme SHMT1
2024 Spoke 5 Oncology and innovative therapies Preclinical studies on fundamental disease mechanisms

Sharon Spizzichino, Federica Di Fonzo, Chiara Marabelli, Angela Tramonti, Antonio Chaves-Sanjuan, Alessia Parroni, Giovanna Boumis, Francesca Romana Liberati, Alessio Paone, Linda Celeste Montemiglio, Matteo Ardini, Arjen J. Jakobi, Alok Bharadwaj, Paolo Swuec, Gian Gaetano Tartaglia, Alessandro Paiardini, Roberto Contestabile, Antonello Mai, Dante Rotili, Francesco Fiorentino, Francesca Cutruzzolà

Haplotypes, Genotypes, and DNA Methylation Levels of Neuromedin U Gene Are Associated with Cardio-Metabolic Parameters: Results from the Moli-sani Study
2025 Spoke 1 Cardiovascular diseases Preclinical studies on fundamental disease mechanisms

Fabrizia Noro, Annalisa Marotta, Simona Costanzo, Benedetta Izzi, Alessandro Gialluisi, Amalia De Curtis, Antonietta Pepe, Sarah Grossi, Augusto Di Castelnuovo, Chiara Cerletti, Maria Benedetta Donati, Giovanni de Gaetano, Francesco Gianfagna, Licia Iacoviello; Moli-sani Study Investigators

Stenosing Crohn’s disease patients display gut autophagy/oxidative stress imbalance
2024 Spoke 1 Metabolic diseases and systemic inflammation Preclinical studies on fundamental disease mechanisms

Leonardo Schirone, Maria Carla Di Paolo, Daniele Vecchio, Cristina Nocella, Alessandra D’Amico, Riccardo Urgesi, Lorella Pallotta, Gianfranco Fanello, Giuseppe Villotti, Maria Giovanna Graziani, Mariangela Peruzzi, Elena De Falco, Roberto Carnevale, Sebastiano Sciarretta, Giacomo Frati, Cristiano Pagnini

Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma
2024 Spoke 1 Oncology and innovative therapies

Giulia Grisendi, Massimiliano Dall’Ora, Giulia Casari, Giliola Spattini, Moein Farshchian Aurora Melandri, Valentina Masciale, Fabio Lepore, Federico Banchelli, Riccardo Cuoghi Costantini, Angela D’Esposito, Chiara Chiavelli, Carlotta Spano, Andrea Spallanzani, Tiziana Petrachi, Elena Veronesi, Manuela Ferracin, Roberta Roncarati, Jonathan Vinet, Paolo Magistri, Barbara Catellani, Olivia Candini, Caterina Marra, Albino Eccher, Luca Reggiani Bonetti, Edwin M. Horwitz, Fabrizio Di Benedetto, Massimo Dominici

TLR4 Downregulation Identifies High-Risk HPV Infection and Integration in H-SIL and Squamous Cell Carcinomas of the Uterine Cervix
2024 Spoke 4 Oncology and innovative therapies

Angela Santoro, Giuseppe Angelico, Damiano Arciuolo, Giulia Scaglione, Belen Padial Urtueta, Gabriella Aquino, Noemy Starita, Maria Lina Tornesello, Rosalia Anna Rega, Maria Carmela Pedicillo, Manuel Mazzucchelli, Ilenia Sara De Stefano, Rosanna Zamparese, Giuseppina Campisi,Giorgio Mori, Gian Franco Zannoni, Giuseppe Pannone

Exploring the Link between BMI and Aggressive Histopathological Subtypes in Differentiated Thyroid Carcinoma—Insights from a Multicentre Retrospective Study
2024 Spoke 4 Metabolic diseases and systemic inflammation Oncology and innovative therapies

Giacomo Di Filippo, Gian Luigi Canu, Giovanni Lazzari 1,Dorin Serbusca,Eleonora Morelli,Paolo Brazzarola,Leonardo Rossi,Benard Gjeloshi,Mariangela Caradonna ,George Kotsovolis,Ioannis Pliakos,Efthymios Poulios ,Theodosios Papavramidis,Federico Cappellacci, Pier Francesco Nocini, Pietro Giorgio Calò, Gabriele Materazzi, Fabio Medas

  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. 9
  11. 10